Clinical Research
Clinical trials outsourcing to India to top $1000 million by 2010. Clinical trials outsourcing has the potential to touch Rs. 5,000 crore (over $1,241.9 million) by 2010, according to a McKinsey report. India is establishing itself as a hub for clinical trials with more than 10 large multinational pharmaceutical companies and leading CROs (Contract Research Organizations) based here. India’s $100-120 million contract research market is growing at 20-25% each year, driven by the following factors:
A bright future is awaiting for you. India is fast emerging as a preferred hub for CROs and SMOs, providing a cost and skill base to support affordable drug development. Transnational business partnerships are also on the rise.
With its ever-growing capabilities in clinical development, acceptance of Indian clinical data by USFDA/EMEA and R&D collaborations with US and EU companies, India is all set to make its mark in the global arena for clinical trials